首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis
【2h】

Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis

机译:结核分枝杆菌中ubiA突变对高水平乙胺丁醇耐药性贡献的地理差异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis. We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5% ± 6.5% of the African EMB-resistant isolates but in only 9.5% ± 1.5% of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment.
机译:乙胺丁醇(EMB)耐药性可以通过多步过程演变,而ubiA(Rv3806c)基因中的突变似乎是结核分枝杆菌中高水平EMB耐药性的原因。我们评估了源自非洲和韩国的EMB耐药菌株中ubiA和embB(Rv3795)突变的患病率。在两个来源的菌株之间,未观察到embB突变频率的差异。但是,ubiA突变存在于非洲EMB耐药菌株中的45.5%±6.5%,而韩国EMB耐药菌株中只有9.5%±1.5%。与EMB抗性相关的ubiA突变位于编码蛋白质跨膜结构域的区域,而embB突变位于编码膜外结构域的区域。需要更大的研究来调查ubiA突变增加的原因,以作为非洲国家对EMB的高水平耐药的途径,例如在结核病治疗期间延长EMB的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号